Psychoactive substances are natural or synthetic substances that act on the central nervous system and alter mental processes such as mood, perception, cognition, consciousness, and behaviour. These substances may be legally prescribed medications (e.g., pain medications or sedatives), legally available substances such as alcohol or caffeine, or controlled or illicit drugs. Psychoactive substances can be used for medical, social, cultural, or recreational purposes, but some carry risks of misuse, dependence, and health or social harms when used in harmful ways.
Psychoactive Substances
The Role of Faith Communities in Addressing Substance Use and Crime – Reading List (Part 2)
In this second reading list, we continue exploring the growing evidence on the role and contribution of faith communities and faith-based organisations in addressing substance use and crime, with a particular focus on treatment engagement...
2024 NIDA International Forum: Call for Research Poster Abstracts and Travel Award Requests
Call for Research Poster Abstract Submissions and Travel Award Requests Submission Deadline: January 14, 2024 Present your international drug use and addiction research during the 2024 NIDA International Forum, which will be held June 14–17...
Carfentanil Detected in Counterfeit Tablets and Powders: What the Substance Use Workforce Should Know
A new health alert reports carfentanil in counterfeit “M30” tablets and powders seized at the United States Southwest border. Carfentanil is an extremely potent synthetic opioid, and some tablets contained it without any fentanyl. The findings highlight how the appearance of an illicit tablet or powder cannot reliably indicate its contents or strength. Prevention, treatment and recovery professionals should reinforce overdose awareness, naloxone access and timely connections to care. Law enforcement, laboratories and public health partners should follow safe handling protocols, test comprehensively and share emerging drug market information quickly.
Humanitarian settings and Use of Substances: CBT as a model of care
Attendance
online
ISSUP Kazakhstan, ISSUP Indonesia and ISSUP Sri Lanka, welcome you to a three-part part webinar series on Cognitive Behavioural Therapy (CBT) in the Treatment of Substance Use Disorders.
The product may not be what it says: What emerging synthetic drugs and dangerous mixtures mean for practice
The clearest message from our recent ISSUP Global webinar was a simple but important one: we should stop assuming that an unregulated drug product contains only what it is sold as containing. That uncertainty now has direct implications for prevention, clinical care, recovery support, toxicology, law enforcement, policy and the administration of justice.
Xylazine-Fentanyl Positivity and Concentration in Urine Drug Tests
Abstract Importance The US opioid crisis is currently driven by illicitly manufactured fentanyl combined with an evolving mix of stimulants and adulterants, such as the veterinary sedative xylazine, which further complicate clinical and...
Assessment of the threat posed by highly potent synthetic opioids in Europe
This threat assessment examines the potential risks posed by highly potent synthetic opioids (HPSOs) in Europe over the next two years. Drawing on early warning data, forensic and clinical evidence, and expert input, the report explores how...